<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="courier ; font-style : italic;} BMC Infect DisBMC Infect. DisBMC" exact="Infectious" post="Diseases1471-2334BioMed CentralLondon pmcid: 73295135187 doi: 10.1186/s12879-020-05187-0 : Research Article"/>
 <result pre="to the data. Abstract Background Uganda has experienced seven Ebola" exact="Virus Disease" post="(EVD) outbreaks and four Marburg Virus Disease (MVD) outbreaks"/>
 <result pre="the data. Abstract Background Uganda has experienced seven Ebola Virus" exact="Disease" post="(EVD) outbreaks and four Marburg Virus Disease (MVD) outbreaks"/>
 <result pre="experienced seven Ebola Virus Disease (EVD) outbreaks and four Marburg" exact="Virus Disease" post="(MVD) outbreaks between 2000 and 2019. We investigated the"/>
 <result pre="seven Ebola Virus Disease (EVD) outbreaks and four Marburg Virus" exact="Disease" post="(MVD) outbreaks between 2000 and 2019. We investigated the"/>
 <result pre="in Western Uganda and compared them to non-mining communities in" exact="Central" post="Uganda. Methods A questionnaire was administered and human blood"/>
 <result pre="mine). The unexposed controls group sampled was community members in" exact="Central" post="Uganda far away from any gold mining activity which"/>
 <result pre="artisan gold mining are more likely to be exposed to" exact="infection" post="with either Marburg virus or ebolaviruses, likely due to"/>
 <result pre="for early detection and response to prevent filovirus epidemics. Keywords" exact="Marburg virus disease" post="Ebola virus disease Filovirus Seroprevalence Epidemiology Ebolaviruses Uganda ELISA"/>
 <result pre="detection and response to prevent filovirus epidemics. Keywords Marburg virus" exact="disease" post="Ebola virus disease Filovirus Seroprevalence Epidemiology Ebolaviruses Uganda ELISA"/>
 <result pre="to prevent filovirus epidemics. Keywords Marburg virus disease Ebola virus" exact="disease" post="Filovirus Seroprevalence Epidemiology Ebolaviruses Uganda ELISA Funding http://dx.doi.org/10.13039/100006088National Center"/>
 <result pre="Ebolaviruses Uganda ELISA Funding http://dx.doi.org/10.13039/100006088National Center for Emerging and Zoonotic" exact="Infectious" post="Diseases RFA-CK-13-001 Background Viruses in the genera Ebolavirus and"/>
 <result pre="Uganda ELISA Funding http://dx.doi.org/10.13039/100006088National Center for Emerging and Zoonotic Infectious" exact="Diseases" post="RFA-CK-13-001 Background Viruses in the genera Ebolavirus and Marburgvirus"/>
 <result pre="and Marburgvirus belong to the family Filoviridae and cause classical" exact="viral" post="haemorrhagic fevers (VHFs) in humans, which are associated with"/>
 <result pre="virus (6 outbreaks) and Bundibugyo virus (one outbreak) and four" exact="Marburg virus disease" post="(MVD) outbreaks caused by Marburg virus and Ravn virus"/>
 <result pre="outbreaks) and Bundibugyo virus (one outbreak) and four Marburg virus" exact="disease" post="(MVD) outbreaks caused by Marburg virus and Ravn virus"/>
 <result pre="considered to be at higher risk of exposure to filovirus" exact="infection" post="because of the Rousettus aegyptiacus bats that live in"/>
 <result pre="as a control, unexposed group because it is in the" exact="Central" post="region of the country far from Kitaka and any"/>
 <result pre="1 and 2 above to assess the risk for filovirus" exact="infection" post="between people with direct or indirect exposure to the"/>
 <result pre="of the high response rate (144.8%) during participant recruitment, a" exact="total" post="of 724 individuals were sample (group 1 = 161, group 2 = 138,"/>
 <result pre="that consented to inclusion in the study were interviewed to" exact="complete" post="a risk factor questionnaire and provided their answers verbally."/>
 <result pre="IgG by ELISA at Uganda Virus Research Institute (UVRI)/Centres for" exact="Disease" post="Control (CDC) VHF laboratory, at Entebbe Uganda. Data management"/>
 <result pre="higher-risk exposure groups (miners and their household members) to the" exact="lower" post="risk exposure group (non-miners living within 50 km of the"/>
 <result pre="Immunosorbent Assay (ELISA), which was validated by US Centres for" exact="Disease" post="Control and Prevention (CDC) on known positive and negative"/>
 <result pre="1:3000 and Ebola Ag 1:2000 Dilutions) was applied on the" exact="upper" post="half of the solid phase of a polyvinyl chloride"/>
 <result pre="the solid phase of a polyvinyl chloride microtiter plate (Thermo" exact="Fisher" post="Scientific, USA) and the lower half coated with 100 μl"/>
 <result pre="polyvinyl chloride microtiter plate (Thermo Fisher Scientific, USA) and the" exact="lower" post="half coated with 100 μl of negative/control antigen in PBS"/>
 <result pre="of the control antigen-coated well was subtracted from its corresponding" exact="viral" post="antigen-coated well to yield adjusted OD value. A sample"/>
 <result pre="724 individuals, 291 (40.2%) from the low-risk exposure region in" exact="Central" post="Uganda (Luweero district) and 433 from the high-risk exposure"/>
 <result pre="Most participants were farmers (67.7%) whereas 71.6% of participants had" exact="primary" post="school education or less. Table 1 Summary of participant"/>
 <result pre="positivity at 3.7% (16/433) compared to low-risk exposure group in" exact="Central" post="Uganda at 1.1% (3/291). Specifically, artisanal gold miners who"/>
 <result pre="IgG Seropositive (%) Filovirus IgG Seronegative (%) bAdjusted OR (95%CI)" exact="Total" post="participants (n = 724) 19 (2.6%) 705 (97.4%) Age (years)"/>
 <result pre="(99.04%) &amp;gt;  20 18 (2.9%) 602 (85.4%) 1.9 (0.2–14.7) Gender" exact="Female" post="4 (1.2%) 329 (98.8%) Male 15 (3.8%) 376 (96.2%)"/>
 <result pre="(96.2%) 3.1 (1.01–9.5) a Education Never 5 (4.1%) 117 (95.9%)" exact="Primary" post="10 (2.5%) 387 (97.5%) 0.4 (0.1–1.3) Secondary 4 (2.2%)"/>
 <result pre="(4.1%) 117 (95.9%) Primary 10 (2.5%) 387 (97.5%) 0.4 (0.1–1.3)" exact="Secondary" post="4 (2.2%) 182 (97.9%) 0.3 (0.1–1.4) Tertiary 0 (0%)"/>
 <result pre="virus. We cannot clearly explain why Marburg virus seroprevalence is" exact="lower" post="than that of ebolaviruses, but this is consistent with"/>
 <result pre="3 months [18]. In the same study, bats were protected by" exact="secondary" post="immunity when reinfected with Marburg virus. If a similar"/>
 <result pre="we studied in western Uganda are at higher risk of" exact="infection" post="with filoviruses compared to those living in more developed"/>
 <result pre="near a national park that is comparable to the central" exact="African" post="forest, this makes the mines a more attractive location"/>
 <result pre="has been previously described as a risk factor for Marburg" exact="virus infection" post="in a study in DRC [21] with OR = 13.9, 95%"/>
 <result pre="been previously described as a risk factor for Marburg virus" exact="infection" post="in a study in DRC [21] with OR = 13.9, 95%"/>
 <result pre="predictor of filovirus seropositivity and has been reported in a" exact="partial" post="meta-analysis done on the risk of ebolaviruses transmissions [23]."/>
 <result pre="this study, the findings suggest that there may be filovirus" exact="infections" post="and outbreaks that occur in Sub- Saharan African countries"/>
 <result pre="be filovirus infections and outbreaks that occur in Sub- Saharan" exact="African" post="countries and go undetected by the health care systems."/>
 <result pre="filoviruses in our diagnostic assays caused by either another filovirus" exact="infection" post="or a non-filovirus infection. A similar unpublished study was"/>
 <result pre="at 1.2% (7/564). The seroprevalence of Marburg virus was slightly" exact="lower" post="in our study whereas that of ebolaviruses was higher."/>
 <result pre="8 years apart. Also, the seroprevalence in our study is" exact="lower" post="than 8% and 3% for pooled seroprevalences reported in"/>
 <result pre="25]. Following the West Africa EVD outbreak, reports of asymptomatic" exact="infection" post="in West African populations has been suggested in populations"/>
 <result pre="West Africa EVD outbreak, reports of asymptomatic infection in West" exact="African" post="populations has been suggested in populations who had contact"/>
 <result pre="at 2.6% in non-contacts [26]. Our investigation also reported a" exact="lower" post="seroprevalence of ebolaviruses (2.5%) than pooled seroprevalences reported in"/>
 <result pre="neighbouring Democratic Republic of Congo (DRC) at 10% [19, 27–30]," exact="Central" post="African Republic and Gabon at 11% [31–35], Sudan at"/>
 <result pre="Democratic Republic of Congo (DRC) at 10% [19, 27–30], Central" exact="African" post="Republic and Gabon at 11% [31–35], Sudan at 22%"/>
 <result pre="person was confirmed in our study and this was much" exact="lower" post="than has been reported in other studies [11–17]. However,"/>
 <result pre="serological test was developed and validated by US Centres for" exact="Disease" post="Control and Prevention (CDC) on known positive and negative"/>
 <result pre="continuing to classify these serological results with validation assays including" exact="viral" post="neutralization to confirm if our findings represent true undetected"/>
 <result pre="neutralization to confirm if our findings represent true undetected filovirus" exact="infections" post="in these communities, or through cross-reaction with other viral"/>
 <result pre="filovirus infections in these communities, or through cross-reaction with other" exact="viral" post="infections, or variability in serologic assays performed. Conclusions We"/>
 <result pre="variability in serologic assays performed. Conclusions We conclude that filovirus" exact="infections" post="may go undetected by the health care system in"/>
 <result pre="Kamwenge, near Kitaka mine, are at higher risk of filovirus" exact="infection" post="compared to populations living further away from these cave"/>
 <result pre="compared to populations living further away from these cave environments." exact="Increased" post="surveillance is still critical in detecting and quickly averting"/>
 <result pre="averting future widespread and devastating filovirus epidemics. Abbreviations EVD Ebola" exact="Virus Disease" post="MVD Marburg Virus Disease ELISA Enzyme-linked IgG Immunoglobulin G"/>
 <result pre="future widespread and devastating filovirus epidemics. Abbreviations EVD Ebola Virus" exact="Disease" post="MVD Marburg Virus Disease ELISA Enzyme-linked IgG Immunoglobulin G"/>
 <result pre="devastating filovirus epidemics. Abbreviations EVD Ebola Virus Disease MVD Marburg" exact="Virus Disease" post="ELISA Enzyme-linked IgG Immunoglobulin G AOR Adjusted Odds Ratio"/>
 <result pre="filovirus epidemics. Abbreviations EVD Ebola Virus Disease MVD Marburg Virus" exact="Disease" post="ELISA Enzyme-linked IgG Immunoglobulin G AOR Adjusted Odds Ratio"/>
 <result pre="ELISA Enzyme-linked IgG Immunoglobulin G AOR Adjusted Odds Ratio VHF" exact="Viral" post="Haemorrhagic Fever EPI Expanded Program for Immunization UVRI Uganda"/>
 <result pre="IgG Immunoglobulin G AOR Adjusted Odds Ratio VHF Viral Haemorrhagic" exact="Fever" post="EPI Expanded Program for Immunization UVRI Uganda Virus Research"/>
 <result pre="UVRI Uganda Virus Research Institute CDC United States Centres for" exact="Disease" post="Control and Prevention OR Odds Ratio PBS Phosphate buffered"/>
 <result pre="acid) OD Optical Density NTF National Task Force SD Standard" exact="Deviation" post="RR Risk Ratio DRC Democratic Republic Congo Publisher’s Note"/>
 <result pre="do not necessarily reflect the opinions of the Centers for" exact="Disease" post="Control and Prevention or the institutions with which the"/>
 <result pre="a PhD in Epidemiology currently working as an Epidemiologist for" exact="Viral" post="Haemorrhagic Fevers at Uganda Virus Research Institute. He is"/>
 <result pre="in Epidemiology currently working as an Epidemiologist for Viral Haemorrhagic" exact="Fevers" post="at Uganda Virus Research Institute. He is also a"/>
 <result pre="at Makerere University, Kampala Uganda, with a research focus on" exact="infectious disease" post="epidemiology. The corresponding author and the co-authors have long"/>
 <result pre="Makerere University, Kampala Uganda, with a research focus on infectious" exact="disease" post="epidemiology. The corresponding author and the co-authors have long"/>
 <result pre="the co-authors have long experience with surveillance and research on" exact="viral" post="haemorrhagic fevers working with US CDC Viral Special Pathogens"/>
 <result pre="and research on viral haemorrhagic fevers working with US CDC" exact="Viral" post="Special Pathogens Branch and Uganda Virus Research Institute where"/>
 <result pre="and epidemiology of VHFs including ebolaviruses, Marburg virus, Rift Valley" exact="Fever" post="virus, Crimean-Congo haemorrhagic fever and other high consequence emerging"/>
 <result pre="Agreement between Uganda Virus Research Institute and US Centres for" exact="Disease" post="Control and Prevention (CDC). Availability of data and materials"/>
 <result pre="L, Okot C, Shoemaker T, et al. Multidistrict outbreak of" exact="Marburg virus disease" post="- Uganda, 2012. J Infect Dis. 2015;212 Suppl 2(Suppl"/>
 <result pre="C, Shoemaker T, et al. Multidistrict outbreak of Marburg virus" exact="disease" post="- Uganda, 2012. J Infect Dis. 2015;212 Suppl 2(Suppl"/>
 <result pre="Wamala JF, Byaruhanga E, Bwire GS, et al. Outbreak of" exact="Marburg hemorrhagic fever" post="among miners in kamwenge and ibanda Districts, Uganda, 2007."/>
 <result pre="R, et al. Seasonal pulses of Marburg virus circulation in" exact="juvenile" post="Rousettus aegyptiacus bats coincide with periods of increased risk"/>
 <result pre="filovirus antibodies in humans and imported monkeys: do subclinical filovirus" exact="infections" post="occur worldwide?Med Microbiol Immunol1992181435510.1007/BF001933951579085 13.JohnsonBKOchengDGichogoAOkiroMLibondoDTukeiPMet al.Antibodies against haemorrhagic fever"/>
 <result pre="R Soc Trop Med Hyg19837773173310.1016/0035-9203(83)90216-X6419422 14.van der WaalsFWPomeroyKLGoudsmitJAsherDMGajdusekDCHemorrhagic fever virus" exact="infections" post="in an isolated rainforest area of Central Liberia. Limitations"/>
 <result pre="WaalsFWPomeroyKLGoudsmitJAsherDMGajdusekDCHemorrhagic fever virus infections in an isolated rainforest area of" exact="Central" post="Liberia. Limitations of the indirect immunofluorescence slide test for"/>
 <result pre="Johnson ED, Merlin M, Georges AJ, Abandja J, et al." exact="Antibody" post="prevalence against haemorrhagic fever viruses in randomized representative central"/>
 <result pre="Antibody prevalence against haemorrhagic fever viruses in randomized representative central" exact="African" post="populations. Res Virol. 1989;140(4):319–31. 10.1016/s0923-2516(89)80112-8. 16.JohnsonEDGonzalezJPGeorgesAFilovirus activity among selected"/>
 <result pre="africa: distribution and prevalence of filovirus reactive antibody in the" exact="Central" post="African Republic. Trans R Soc Trop Med Hyg. 1993;87(5):530–5."/>
 <result pre="distribution and prevalence of filovirus reactive antibody in the Central" exact="African" post="Republic. Trans R Soc Trop Med Hyg. 1993;87(5):530–5. 10.1016/0035-9203(93)90075-2."/>
 <result pre="al. Egyptian rousette bats maintain long-term protective immunity against Marburg" exact="virus infection" post="despite diminished antibody levels. Sci Rep. 2017;7:8763. 10.1038/s41598-017-07824-2. 19.Nkoghe"/>
 <result pre="Egyptian rousette bats maintain long-term protective immunity against Marburg virus" exact="infection" post="despite diminished antibody levels. Sci Rep. 2017;7:8763. 10.1038/s41598-017-07824-2. 19.Nkoghe"/>
 <result pre="and Marburg virus antibody prevalence in selected populations of the" exact="Central" post="African RepublicMicrobes Infect20002394410.1016/S1286-4579(00)00287-210717539 21.BauschDGBorchertMGreinTRothCSwanepoelRLibandeMLet al.Risk factors for Marburg hemorrhagic"/>
 <result pre="Marburg virus antibody prevalence in selected populations of the Central" exact="African" post="RepublicMicrobes Infect20002394410.1016/S1286-4579(00)00287-210717539 21.BauschDGBorchertMGreinTRothCSwanepoelRLibandeMLet al.Risk factors for Marburg hemorrhagic fever,"/>
 <result pre="of the Central African RepublicMicrobes Infect20002394410.1016/S1286-4579(00)00287-210717539 21.BauschDGBorchertMGreinTRothCSwanepoelRLibandeMLet al.Risk factors for" exact="Marburg hemorrhagic fever," post="Democratic Republic of the CongoEmerg Infect Dis200391531153710.3201/eid0912.03035514720391 22.TomoriOFabiyiASorungbeASmithAMcCormickJBViral hemorrhagic"/>
 <result pre="Response Team, Aylward B, Barboza P, et al. Ebola virus" exact="disease" post="in West Africa--the first 9 months of the epidemic"/>
 <result pre="S, Houlihan CF, Montesano C, Scott JT, et al. Asymptomatic" exact="infection" post="and unrecognised Ebola virus disease in Ebola-affected households in"/>
 <result pre="Scott JT, et al. Asymptomatic infection and unrecognised Ebola virus" exact="disease" post="in Ebola-affected households in Sierra Leone: a cross-sectional study"/>
 <result pre="epidemiologic and health control issuesJ Infect Dis1999179SupplS65S7510.1086/5142909988167 35.BertheratERenautANabiasRDubreuilGGeorges-CourbotMCLeptospirosis and Ebola" exact="virus infection" post="in five gold-panning villages in northeastern GabonAm J Trop"/>
 <result pre="and health control issuesJ Infect Dis1999179SupplS65S7510.1086/5142909988167 35.BertheratERenautANabiasRDubreuilGGeorges-CourbotMCLeptospirosis and Ebola virus" exact="infection" post="in five gold-panning villages in northeastern GabonAm J Trop"/>
 <result pre="villages in northeastern GabonAm J Trop Med Hyg.19996061061510.4269/ajtmh.1999.60.61010348236 36.BaronRCMcCormickJBZubeirOAEbola virus" exact="disease" post="in southern Sudan: hospital dissemination and intrafamilial spreadBull World"/>
 <result pre="and intrafamilial spreadBull World Health Organ19836199710036370486 37.MeunierDMJohnsonEDGonzalezJPGeorges-CourbotMCMadelonMCGeorgesAJCurrent serologic data on" exact="viral" post="hemorrhagic fevers in the Central African RepublicBull Soc Pathol"/>
 <result pre="Organ19836199710036370486 37.MeunierDMJohnsonEDGonzalezJPGeorges-CourbotMCMadelonMCGeorgesAJCurrent serologic data on viral hemorrhagic fevers in the" exact="Central" post="African RepublicBull Soc Pathol Exot Filiales19878051613607998 38.BoureePBergmannJ-FFEbola virus infection"/>
 <result pre="37.MeunierDMJohnsonEDGonzalezJPGeorges-CourbotMCMadelonMCGeorgesAJCurrent serologic data on viral hemorrhagic fevers in the Central" exact="African" post="RepublicBull Soc Pathol Exot Filiales19878051613607998 38.BoureePBergmannJ-FFEbola virus infection in"/>
 <result pre="in the Central African RepublicBull Soc Pathol Exot Filiales19878051613607998 38.BoureePBergmannJ-FFEbola" exact="virus infection" post="in man: a serological and epidemiological survey in the"/>
 <result pre="the Central African RepublicBull Soc Pathol Exot Filiales19878051613607998 38.BoureePBergmannJ-FFEbola virus" exact="infection" post="in man: a serological and epidemiological survey in the"/>
 <result pre="T, Kuehne AI, Stonier SW, et al. Human survivors of" exact="disease" post="outbreaks caused by Ebola or Marburg virus exhibit cross-reactive"/>
</results>
